INOVIO PHARMACEUTICALS, INC. (INO) Operating cash flow 2016–2025
INOVIO PHARMACEUTICALS, INC. (INO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$88.6MFY2025 · since FY2016: -$62.6M → -$88.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.6M | +14.8% |
| FY2024 | -$104.1M | +16.3% |
| FY2023 | -$124.4M | +42.5% |
| FY2022 | -$216.2M | -0.2% |
| FY2021 | -$215.7M | -21.2% |
| FY2020 | -$178.0M | -81.9% |
| FY2019 | -$97.9M | -33.0% |
| FY2018 | -$73.6M | -16.4% |
| FY2017 | -$63.2M | -1.0% |
| FY2016 | -$62.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice